Shares of PPCB (NASDAQ:PPCB – Free Report) are scheduled to reverse split before the market opens on Monday, May 18th. The 1-25 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, May 17th.
PPCB Stock Performance
Shares of NASDAQ PPCB traded down $0.02 on Thursday, reaching $0.07. 3,387,197 shares of the company’s stock traded hands, compared to its average volume of 1,566,648. PPCB has a 12 month low of $0.07 and a 12 month high of $10.81. The company has a 50 day moving average of $0.11.
PPCB (NASDAQ:PPCB – Get Free Report) last announced its earnings results on Thursday, May 14th. The company reported ($0.28) earnings per share for the quarter.
Analyst Upgrades and Downgrades
View Our Latest Analysis on PPCB
About PPCB
Propanc Biopharma, Inc is a healthcare company. It focuses on the development of cancer treatments for pancreatic, ovarian and colorectal cancer primarily in Australia. The Company’s products include PRP and PRP-DCM. Propanc Biopharma, Inc, formerly known as Propanc Health Group Corporation, is based in Camberwell, Australia.
Featured Stories
- Five stocks we like better than PPCB
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for PPCB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PPCB and related companies with MarketBeat.com's FREE daily email newsletter.
